FREE Consultations

Ditropan & Ditropan XL Dementia Lawyers

Ditropan & Ditropan XL Dementia Lawsuit

Hold Drug Manufacturers Accountable | Learn About Your Legal Options with Schlesinger Law Offices.

As prescribed treatments for overactive bladder (OAB), these medications have garnered attention due to concerns surrounding their association with dementia and related symptoms. The safety of patients should always be a top priority, and the potential risks linked to these drugs have raised important questions within the medical community and among affected individuals and their families.

Our firm is committed to fighting for your rights and advocating for fair compensation for the injuries and suffering caused by these drugs. We believe in holding drug manufacturers accountable for their actions and omissions when it comes to warning patients about potential risks. If you or a loved one took these medications and subsequently experienced dementia or related symptoms, you deserve to have your voice heard and your rights protected.

By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy

The Link Between Ditropan & Ditropan XL and Dementia Risk

Drugs prescribed to treat overactive bladder (OAB) – like Ditropan and Ditropan XL – may increase the risk of dementia. Drug manufacturers that make these medications, such as Janssen and its parent company, Johnson & Johnson, may face lawsuits because they did not adequately warn patients that the drugs are causally associated with dementia and related symptoms such as memory loss, language difficulties, confusion, loss of the ability to care for oneself, and personality changes.  

Several studies have identified a connection between using Ditropan XL and an increased risk of developing dementia. The risk may be 1.5 to 2 times higher for individuals who have taken the medication, and it can persist for up to 20 years after discontinuation.

People or loved ones of those who took drugs to treat their OAB may be eligible to take legal action against these drug companies and may obtain compensation for their injuries.

Ditropan Lawyers in Fort Lauderdale

OUR results

$60 Million


The firm obtained a $60,000,000.00 verdict against General Motors after the vehicle the McGee family was driving was engulfed in flames due to a fuel-fed fire, and Shane McGee was tragically burned to death. Gregg helped litigate the matter and prepare it for trial.

$37 Million


Jury verdict for the family of our client, who died of lung cancer after a lifetime of smoking R.J. Reynolds and Philip Morris cigarettes.

$20 Million


Attorneys Scott Schlesinger and Jonathan Gdanski recently secured a $20 million jury verdict for Herbert Landi, the widower of a woman who died of lung cancer in 1999 caused by smoking cigarettes.

Explore Your Legal Options

Please get in touch with the team at Schlesinger Law Offices for a free consultation to learn more about your potential legal options if you took this drug and later developed dementia or if a loved one took the drug and was later diagnosed with the condition. The Schlesinger firm is evaluating legal claims for people between 50 and 79 years old who have used drugs to treat OAB and have subsequently been diagnosed with dementia or are experiencing related symptoms of memory loss.